We are live on
!
Find out more
MCMU
MIC Capital Management (UK) Portfolio holdings
AUM
$394M
1-Year Est. Return
25.64%
This Fund
S&P 500
This Quarter
Est. Return
+34.56%
1 Year Est. Return
+25.64%
3 Year Est. Return
+67.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$394M
AUM Growth
+$41.9M
(+12%)
Cap. Flow
-$53.9M
Cap. Flow
% of AUM
-13.66%
Top 10 Holdings %
Top 10 Hldgs %
94.65%
Holding
17
New
3
Increased
1
Reduced
3
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$18.8M |
| 2 |
Capital One
COF
|
+$9.18M |
| 3 |
BLLN
BillionToOne Inc
BLLN
|
+$447K |
| 4 |
Recursion Pharmaceuticals
RXRX
|
+$3 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$38.6M |
| 2 |
KLAR
Klarna Group
KLAR
|
+$29.3M |
| 3 |
Inseego
INSG
|
+$8.53M |
| 4 |
Hayward Holdings
HAYW
|
+$5.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.61% |
| 2 | Industrials | 28.85% |
| 3 | Consumer Discretionary | 16.98% |
| 4 | Financials | 6.82% |
| 5 | Technology | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hayward Holdings
HAYW
$2.95B
| $107M | 27.09% |
6,171,527
-401,149
| -6% | -$5.86M |
|
|
2
Revolution Medicines
RVMD
$45B
| $99.6M | 25.25% |
531,733
-264,000
| -33% | -$38.6M |
|
|
3
Recursion Pharmaceuticals
RXRX
$1.95B
| $35.4M | 8.98% |
9,644,033
+1
| +0% | +$3 |
|
4
Restaurant Brands International
QSR
$28B
| $28M | 7.1% |
386,203
| – | – |
|
5
Coupang
CPNG
$27.5B
| $24.5M | 6.22% |
1,412,946
| – | – |
|
6
Grab
GRAB
$14B
| $18.9M | 4.78% |
5,000,000
| – | – |
|
7
Meta Platforms (Facebook)
META
$1.57T
| $18.8M | 4.76% |
33,300
| – | – |
|
|
KLAR
8
Klarna Group
KLAR
$5.46B
| $17.3M | 4.38% |
852,498
-1,862,430
| -69% | -$29.3M |
|
|
9
Alibaba
BABA
$281B
| $14.4M | 3.65% |
+150,000
| New | +$18.8M |
|
|
10
Capital One
COF
$135B
| $9.63M | 2.44% |
+48,011
| New | +$9.18M |
|
11
Neumora Therapeutics
NMRA
$246M
| $7.58M | 1.92% |
4,460,700
| – | – |
|
12
monday.com
MNDY
$3.85B
| $4.78M | 1.21% |
66,000
| – | – |
|
13
Rocket Lab Corp
RKLB
$41.1B
| $3.62M | 0.92% |
35,628
| – | – |
|
14
Archer Aviation
ACHR
$4.4B
| $3.31M | 0.84% |
700,000
| – | – |
|
15
Lyell Immunopharma
LYEL
$352M
| $1.22M | 0.31% |
87,028
| – | – |
|
|
BLLN
16
BillionToOne Inc
BLLN
$4.69B
| $587K | 0.15% |
+4,892
| New | +$447K |
|
|
17
Inseego
INSG
$69.6M
| – | – |
-767,165
| Closed | -$8.53M |
|
Similar funds
ACM
XSC
SSW
FMTCOCP
RGC
ICM
PCM
KC
MIC Capital Management (UK)'s Q2 2026 Portfolio in Review
As of Q2 2026, MIC Capital Management (UK) held 17 positions worth $394M, up 12% from $352M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
MIC Capital Management (UK) withdrew a net $53.9M in Q2 2026, closing 1 position and reducing 3 holdings. Its most notable exit was Inseego, an estimated $8.53M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 33% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, MIC Capital Management (UK) opened a new position in Alibaba worth $14.4M.
- MIC Capital Management (UK)'s largest Q2 2026 buy was Alibaba: 150,000 shares worth $14.4M.
- MIC Capital Management (UK) added most to Recursion Pharmaceuticals in Q2 2026, an estimated $3 increase.
- MIC Capital Management (UK)'s biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $38.6M.
- MIC Capital Management (UK) fully exited Inseego in Q2 2026, selling an estimated $8.53M.
- MIC Capital Management (UK)'s ten largest holdings make up 95% of its $394M portfolio in Q2 2026.
- MIC Capital Management (UK) opened 3 new positions and closed 1 in Q2 2026.
- MIC Capital Management (UK)'s portfolio value rose 12% quarter-over-quarter to $394M.
Based on MIC Capital Management (UK)'s 13F filing for Q2 2026, filed 10 Aug 2026.